2-[(5-Chloro-1,3-dimethyl-1H-pyrazol-4-yl)formamido]-N-(2,6-dimethylphenyl)acetamide

Catalog No. :
ACSQKR250
CAS No. :
956372-10-4
Molecular Formula :
C16H19ClN4O2
Molecular Weight :
334.81

IUPAC Name:5-chloro-N-(2-((2,6-dimethylphenyl)amino)-2-oxoethyl)-1,3-dimethyl-1H-pyrazole-4-carboxamide

2-[(5-Chloro-1,3-dimethyl-1H-pyrazol-4-yl)formamido]-N-(2,6-dimethylphenyl)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$336.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-[(5-Chloro-1,3-dimethyl-1H-pyrazol-4-yl)formamido]-N-(2,6-dimethylphenyl)acetamide
IUPAC Name5-chloro-N-(2-((2,6-dimethylphenyl)amino)-2-oxoethyl)-1,3-dimethyl-1H-pyrazole-4-carboxamide
MDL No.MFCD03305945
Molecular FormulaC16H19ClN4O2
Molecular Weight334.81
SMILESO=C(NC1=C(C)C=CC=C1C)CNC(C2=C(Cl)N(C)N=C2C)=O
InChI KeyFQYJRMVSXYDBHO-UHFFFAOYSA-N
Synonym5-CHLORO-N-[2-(2,6-DIMETHYLANILINO)-2-OXOETHYL]-1,3-DIMETHYL-1H-PYRAZOLE-4-CARBOXAMIDE;2-[(5-chloro-1,3-dimethyl-1H-pyrazol-4-yl)formamido]-N-(2,6-dimethylphenyl)acetamide;1H-Pyrazole-4-carboxamide, 5-chloro-N-[2-[(2,6-dimethylphenyl)amino]-2-oxoethyl]-1,3-dimethyl-
CAS No.956372-10-4

Synthetic Route by SureRoute

1. ACSQKR250 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWMPR305 route compound structure diagram
    ACWMPR30518865-38-8 In Stock
  2. Plus
  3. ACASXM479 route compound structure diagram
    ACASXM47927006-82-2 In Stock
  4. Then
  5. ACSQKR250 route product structure diagram
    ACSQKR250956372-10-4
Inquiry

2. ACSQKR250 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXSVE904 route compound structure diagram
    ACXSVE90421436-98-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSQKR250 route product structure diagram
    ACSQKR250956372-10-4
Inquiry

Comments (0)